Skip to Content
Merck

Skip To

M2137

N-Methyl-DL-aspartic acid

Synonym(s):

(±)-2-(Methylamino)succinic acid, NMA

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View
Pack SizeSKUAvailabilityPrice

About This Item

Linear Formula:
HOCOCH2CH(NHCH3)COOH
CAS Number:
Molecular Weight:
147.13
PubChem Substance ID:
UNSPSC Code:
12352200
Beilstein/REAXYS Number:
1724430
MDL number:
Pricing and availability is not currently available.
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


assay

≥98% (TLC)

form

powder

color

white

SMILES string

CNC(CC(O)=O)C(O)=O

InChI

1S/C5H9NO4/c1-6-3(5(9)10)2-4(7)8/h3,6H,2H2,1H3,(H,7,8)(H,9,10)

InChI key

HOKKHZGPKSLGJE-UHFFFAOYSA-N

Biochem/physiol Actions

N-Methyl-DL-aspartic acid is a derivative of aspartic acid.


Storage Class

13 - Non Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



B Häggman-Henrikson et al.
Journal of oral rehabilitation, 44(10), 800-826 (2017-09-09)
This health technology assessment evaluated the efficacy of pharmacological treatment in patients with oro-facial pain. Randomised controlled trials were included if they reported pharmacological treatment in patients ≥18 years with chronic (≥3 months) oro-facial pain. Patients were divided into subgroups:
Yan Luo et al.
BMJ open, 8(12), e023222-e023222 (2018-12-12)
Depressive disorders are the most common, burdensome and costly mental disorders. Their treatments have developed through the past decades and we now have more than a dozen new generation antidepressants, while a series of guidelines have been published to provide
Andrea C Tricco et al.
BMC medicine, 14(1), 216-216 (2016-12-23)
Although serotonin (5-HT3) receptor antagonists are effective in reducing nausea and vomiting, they may be associated with increased cardiac risk. Our objective was to examine the comparative safety and effectiveness of 5-HT3 receptor antagonists (e.g., dolasetron, granisetron, ondansetron, palonosetron, tropisetron)